Evaluation to Differentiate Between Tumor Lesions and the Parenchyma in Partial Nephrectomies for Renal Tumors Based on Quantitative Fluorescence Imaging Using Indocyanine Green Dye
Affiliations
Introduction: Near-infrared fluorescence imaging with indocyanine green is a useful tool during partial nephrectomy. Because an accurate method for judging hasn't been established yet, the success rate may be slightly different and inconsistent.
Materials And Methods: A total of 21 cases with suspected renal cancers who had undergone a partial nephrectomy were enrolled. We examined differences in the success rate between malignant lesions and the parenchyma by quantifying fluorescence in the pre-resection and phases.
Results: Pre-resection imaging showed a significant degradation of fluorescence in the focused lesion in 76.2% (16/21) of cases. A significant degradation was observed in 73.7% (14/19) of the total malignant lesions, 70.5% (12/17) of cases with a clear cell lesion, 100% (2/2) of cases with non-clear cell lesions, and 100% (2/2) of benign angiomyolipomas. In contrast, imaging of the resected specimens showed a significant degradation in fluorescence of the focused lesions in 85.7% (18/21) of cases. A significantly degradation was observed in 84.2% (16/19) of the total malignant lesions, 82.3% (14/17) of cases with a clear cell lesion, 100% (2/2) of cases with non-clear cell lesions, and 100% (2/2) of benign angiomyolipomas.
Conclusion: We firstly evaluated the efficacy of quantitative indocyanine green-based fluorescence as an objective method.
Tang J, Wang R, Fang Z, Zhu P, Yao J, Yang H World J Clin Oncol. 2024; 15(11):1435-1443.
PMID: 39582616 PMC: 11514421. DOI: 10.5306/wjco.v15.i11.1435.
Fransvea P, Miccini M, Rondelli F, Brisinda G, Costa A, Garbarino G J Clin Med. 2024; 13(16).
PMID: 39201036 PMC: 11355299. DOI: 10.3390/jcm13164895.
Cassinotti E, Al-Taher M, Antoniou S, Arezzo A, Baldari L, Boni L Surg Endosc. 2023; 37(3):1629-1648.
PMID: 36781468 PMC: 10017637. DOI: 10.1007/s00464-023-09928-5.
Teranishi K Int J Mol Sci. 2022; 23(13).
PMID: 35806231 PMC: 9266568. DOI: 10.3390/ijms23137228.
Mastronardi M, Fracon S, Scomersi S, Fezzi M, Bortul M Breast J. 2022; 2022:5142100.
PMID: 35711883 PMC: 9187268. DOI: 10.1155/2022/5142100.